Ok-Nam Bae Selected Research

Ok-Nam Bae Research Topics

Disease

18	Thrombosis (Thrombus) 01/2022 - 03/2002
11	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 03/2002
9	Ischemia 10/2022 - 08/2011
8	Stroke (Strokes) 10/2022 - 05/2012
8	Ischemic Stroke 07/2021 - 01/2013
7	Edema (Dropsy) 07/2021 - 11/2015
6	Inflammation (Inflammations) 12/2020 - 04/2015
6	Neoplasms (Cancer) 01/2019 - 03/2002
5	Brain Ischemia (Cerebral Ischemia) 10/2022 - 08/2011
5	Infarction (Infarctions) 10/2022 - 08/2011
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 12/2007
4	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 06/2012
4	Hemorrhage 10/2019 - 10/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2020 - 08/2011
3	Acute Kidney Injury (Acute Renal Failure) 12/2018 - 01/2015
3	Hypertension (High Blood Pressure) 09/2014 - 04/2003
2	Diabetic Angiopathies (Diabetic Angiopathy) 09/2023 - 01/2018
2	Brain Injuries (Brain Injury) 07/2021 - 08/2013
2	Hemolysis 09/2019 - 01/2019
2	Pain (Aches) 11/2015 - 01/2015
2	Parkinson Disease (Parkinson's Disease) 05/2009 - 07/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2023
1	Reperfusion Injury 02/2022
1	Methemoglobinemia 12/2019
1	Hemolytic Anemia 12/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Carcinogenesis 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 08/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Arthritis (Polyarthritis) 06/2017
1	Phototoxic Dermatitis (Phototoxicity) 05/2017

Drug/Important Bio-Agent (IBA)

7	Neuroprotective AgentsIBA 10/2022 - 08/2011
6	CarnosineIBA 07/2021 - 01/2013
6	PhosphatidylserinesIBA 01/2021 - 09/2009
6	ArsenicIBA 01/2019 - 03/2002
4	Drinking WaterIBA 01/2019 - 03/2002
3	DipeptidesIBA 07/2021 - 01/2013
3	Thrombin FDA Link 01/2019 - 01/2003
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 10/2012
3	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 01/2015
3	phorbolIBA 08/2016 - 01/2016
3	arseniteIBA 12/2007 - 03/2002
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2022 - 12/2012
2	Emodin (Archin)IBA 02/2022 - 09/2014
2	LipopolysaccharidesIBA 12/2020 - 11/2015
2	CytokinesIBA 12/2020 - 06/2017
2	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 07/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 12/2016
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2019 - 12/2012
2	SilverIBA 01/2019 - 06/2011
2	CarrageenanIBA 11/2016 - 08/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 04/2014
2	OxazoloneIBA 01/2016 - 04/2015
2	asiatic acidIBA 01/2014 - 06/2012
2	CollagenIBA 12/2012 - 10/2011
2	Sulfhydryl Compounds (Thiols)IBA 07/2010 - 01/2005
2	monomethylarsonous acidIBA 09/2009 - 11/2008
1	phthalic acid (phthalate)IBA 09/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2022
1	Free Radical ScavengersIBA 10/2022
1	N-Methylaspartate (NMDA)IBA 10/2022
1	disufenton sodium (NXY 059)IBA 10/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2022
1	AminesIBA 01/2022
1	ZincIBA 07/2021
1	Tight Junction ProteinsIBA 07/2021
1	Matrix Metalloproteinases (MMPs)IBA 07/2021
1	titanium dioxide (Titania)FDA Link 01/2021
1	Liposomes (Liposome)IBA 12/2020
1	Free RadicalsIBA 04/2020
1	OccludinIBA 03/2020
1	Oxygen (Dioxygen)IBA 03/2020
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2019
1	SulfonamidesIBA 12/2019
1	Dapsone FDA Link 12/2019
1	peoniflorinIBA 10/2019
1	ginsenoside Rg3IBA 09/2019
1	chrysinIBA 05/2019
1	CarcinogensIBA 01/2019
1	P-SelectinIBA 01/2019
1	Eptifibatide (Integrilin)FDA Link 01/2019
1	sericetinIBA 12/2018
1	SmokeIBA 10/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2018
1	GinsenosidesIBA 08/2018
1	jasplakinolideIBA 08/2018
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2018
1	erucylphosphocholineIBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 06/2017
1	Freund's AdjuvantIBA 06/2017
1	Cystatin AIBA 05/2017
1	ElafinIBA 05/2017
1	Caspase 3 (Caspase-3)IBA 05/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017

Therapy/Procedure

11	Therapeutics 10/2022 - 05/2012
3	Intravenous Administration 01/2022 - 10/2018
2	Oral Administration 10/2011 - 01/2003